Sarepta Therapeutics, Inc. SRPT Business Segments — Income Tax Expense Benefit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — income tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s business segments — income tax expense benefit?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — income tax expense benefit of $12.22M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — income tax expense benefit changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — income tax expense benefit decreased by 80.9% year-over-year, from $63.99M to $12.22M.
- What does business segments — income tax expense benefit mean?
- The provision for income taxes allocated to the segment based on its taxable earnings or jurisdictional requirements. This metric captures the tax impact on the segment's bottom-line performance. It is essential for understanding the segment's net contribution after accounting for fiscal obligations.